A number of recent studies have revealed that an IFN-related DNA damage-resistance signature (IRDS) predicts resistance to chemotherapy and radiation therapy in breast cancer, glioblastoma, and many other cancers (Weichselbaum et al, 2008; Duarte et al, 2012). Here, IFNA1 is linked to glioblastoma.